Search Results 101-110 of 1932 for ☆ 13210007 ☆텔레@admallsite☆☆쇼핑노하우☆☆☆텔레@admallsite☆☆☆쇼핑채널☆☆☆

  1. Study to Determine the Safety and Effectiveness of CLS-TA in Combination with an Intravitreal Anti-VEGF Agent in Subjects with Retinal Vein Occlusion - Mayo Clinic

    Study to Determine the Safety and Effectiveness of CLS-TA in Combination with an Intravitreal Anti-VEGF Agent in Subjects with Retinal Vein Occlusion · Overview.

  2. Senyo Health With Substance Use Disorder (SUD) In Primary Care - Mayo Clinic

    The purpose of this study is to examine the barriers, facilitators, and optimal processes for implementing a digitally enhanced screening, brief intervention, ...

  3. Cumulative Stress in Older Adult Latinos - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. NOHARM Aim 3 - Clinical Trials

    The purpose of this study is an effort to enrich the ongoing NOHARM pragmatic trial. NOHARM AIM 3 will use a mixed methods analysis of patient and care team ...

  5. Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients with Medically Refractory Partial Epilepsy - Mayo Clinic

    About this study. To investigate whether MR-guided laser induced thermal therapy in patients diagnosed with focal lesional epilepsy using the Visualase ...

  6. Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Characterization of Biliary Cell-derived Organoids from Bile of PSC and Non-PSC Patients - Mayo Clinic

    About this study. The objectives of this study are to establish and perpetuate human biliary cell-derived organoids, to assess genetic and signaling pathway ...

  8. Shockless IMPLant Evaluation in Replacements - Mayo Clinic

    About this study. The purpose of this study is to demonstrate the event rate of the primary outcome, defined as failure of DFT at a single shock at 10 ...

  9. Long-Term Safety of PF-00547659 in Ulcerative Colitis - Mayo Clinic

    Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to evaluate ...

  10. A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors - Mayo Clinic

    About this study. This is an open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetic (what the body does to the drug), ...